QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development 期刊论文 ONCOTARGET, 2018, 卷号: 9, 期号: 3 作者:  Grau, Michael;  Gu, Juan J.;  Singh, Anil;  Xue, Kai;  Mavis, Cory 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 hexokinase II  rituximab-chemotherapy resistance  lymphoma  glucose metabolism   Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents 期刊论文 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 卷号: 142, 期号: 2 作者:  Xue, Kai;  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Vorinostat  Chemotherapy resistance  Lymphoma  Histone deacetylase inhibitors   Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial 期刊论文 ONCOTARGET, 2016, 卷号: 7, 期号: 22 作者:  Xue, Kai;  Gu, Juan J.;  Zhang, Qunling;  Liu, Xiaojian;  Wang, Jiachen 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/13 cardiac toxicity  doxorubicin  epirubicin  high-sensitivity troponin T   Palbociclib (PD-0332991), a Potent Selective CDK4/6 Inhibitor, Overcomes Therapy-Resistant and Sensitizes Diffuse Large B-Cell Lymphoma Pre-Clinical Models to Chemo-Reagents 会议论文 作者:  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Czuczman, Myron S.;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Metformin Induces p53-Dependent Mitochondrial Stress in Therapy-Sensitive and - Resistant Lymphoma Pre-Clinical Model and Primary Patients Sample with B-Cell Non-Hodgkin Lymphoma (NHL) 会议论文 作者:  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Czuczman, Myron S.;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Dual Inhibition of PKC Delta By Carfilzomib (CFZ) and Ibrutinib Results in Synergistic Activity in Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Pre-Clinical Models and in Primary Tumor Cells Isolated from B-Cell Lymphoma Patients 会议论文 作者:  Zhang, Qunling;  Gu, Juan J.;  Guo, Ye;  Klos, Jacob;  Mavis, Cory 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 JQ1, a Potent c-MYC Inhibitor Overcomes Rituximab-Chemotherapy Resistance in Lymphoma Pre-Clinical Models 会议论文 作者:  Gu, Juan J.;  Zhang, Qunling;  Mavis, Cory;  Czuczman, Myron S.;  Hernandez-Ilizaliturri, Francisco J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Up-Regulation of Hexokinase II (HK) Alters the Glucose Metabolism and Disrupts the Mitochondrial Potential in Aggressive B-Cell Lymphoma Contributing to Rituximab-Chemotherapy Resistance and Is a Clinically Relevant Target for Future Therapeutic Development 会议论文 作者:  Gu, Juan J.;  Singh, Anil;  Mavis, Cory;  Yanamadala, Vivek;  Xue, Kai 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone plus /- Rituximab (CHOP plus /-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone plus /- Rituximab (CEpOP plus /-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568 会议论文 作者:  Xue, Kai;  Gu, Juan J.;  Zhang, Qunling;  Liu, Xiaojian;  Wang, Jiachen 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Vorinostat, a Histone Deacetylase (HDAC) Inhibitor, Is Active in Chemotherapy Resistant B-Cell Non-Hodgkin Lymphoma and Enhances the Anti-Tumor Activity of Chemotherapy Agents 会议论文 作者:  Xue, Kai;  Gu, Juan;  Mavis, Cory;  Hernandez, Francisco;  Czuczman, Myron S. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19